Ambev S.A. [NYSE: ABEV] stock went on a downward path that fall over -1.32% on Friday, amounting to a one-week price increase of more than 1.01%. The company report on March 18, 2022 that Ambev’s 2021 Annual Report on Form 20-F Available on Our Website.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
Ambev S.A. [B3: ABEV3; NYSE: ABEV] announces that the Company’s annual report on Form 20-F for the year ended December 31, 2021 was filed with the U.S. Securities and Exchange Commission – SEC (www.sec.gov) on March 18, 2022 and is available on the Company’s website (ri.ambev.com.br) and also on the Company’s page on SEC’s database (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company’s complete audited financial statements contained in the Form 20-F free of charge, upon request.
To access the full document, please access the following link: click here.
Over the last 12 months, ABEV stock dropped by -0.92%. The one-year Ambev S.A. stock forecast points to a potential upside of 9.39. The average equity rating for ABEV stock is currently 2.70, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $48.77 billion, with 15.74 billion shares outstanding and 4.41 billion shares in the current float. Compared to the average trading volume of 33.68M shares, ABEV stock reached a trading volume of 33415345 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Ambev S.A. [ABEV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABEV shares is $3.30 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABEV stock is a recommendation set at 2.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Ambev S.A. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 13, 2022. While these analysts kept the previous recommendation, BofA Securities raised their target price from $3 to $3.50. The new note on the price target was released on November 03, 2021, representing the official price target for Ambev S.A. stock. Previously, the target price had yet another drop from $4 to $3.50, while Barclays kept a Overweight rating on ABEV stock.
The Average True Range (ATR) for Ambev S.A. is set at 0.08, with the Price to Sales ratio for ABEV stock in the period of the last 12 months amounting to 3.28. The Price to Book ratio for the last quarter was 2.82, with the Price to Cash per share for the same quarter was set at 0.19. Price to Free Cash Flow for ABEV in the course of the last twelve months was 66.55 with Quick ratio for the last quarter at 0.80.
ABEV Stock Performance Analysis:
Ambev S.A. [ABEV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.01. With this latest performance, ABEV shares gained by 14.56% in over the last four-week period, additionally plugging by 4.55% over the last 6 months – not to mention a drop of -0.92% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ABEV stock in for the last two-week period is set at 62.50, with the RSI for the last a single of trading hit 63.71, and the three-weeks RSI is set at 60.27 for Ambev S.A. [ABEV]. The present Moving Average for the last 50 days of trading for this stock 2.69, while it was recorded at 2.99 for the last single week of trading, and 2.83 for the last 200 days.
Insight into Ambev S.A. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Ambev S.A. [ABEV] shares currently have an operating margin of +22.64 and a Gross Margin at +48.21. Ambev S.A.’s Net Margin is presently recorded at +17.39.
Return on Equity for this stock inclined to 16.20, with Return on Assets sitting at 9.33.
Ambev S.A.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.80 and a Current Ratio set at 1.10.
ABEV Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ABEV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Ambev S.A. go to 9.10%.
Ambev S.A. [ABEV] Insider Position Details
Positions in Ambev S.A. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 137 institutional holders increased their position in Ambev S.A. [NYSE:ABEV] by around 131,967,145 shares. Additionally, 123 investors decreased positions by around 124,529,807 shares, while 57 investors held positions by with 1,067,580,710 shares. The mentioned changes placed institutional holdings at 1,324,077,662 shares, according to the latest SEC report filing. ABEV stock had 35 new institutional investments in for a total of 27,659,403 shares, while 32 institutional investors sold positions of 12,258,193 shares during the same period.